clinical trials for retatrutide ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial New GLP-1 obesity drug, retatrutide,
Pay in 4 interest-free payments of $5.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13



:max_bytes(150000):strip_icc()/VWH-GettyImages-2170138295-1e664f5616224ea39b5ba836a469d10b.jpg)






















